BCLI
BRAINSTORM CELL THERAPUTCstockOTC
EODNov 16, 2026
0.95USD-4.040%(-0.04)6,347
BCLI Financials
In Q3 FY 2026 (ended ), BRAINSTORM CELL THERAPUTC (BCLI) reported net income of −$1.73M, operating cash flow of −$704K, and assets of $840K (filed ).
Loading financial statements…
